Michael Mæng
Impact in
-
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Surgery top 0.1%
- Coronary Interventions and Diagnostics
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 206
- Coronary Interventions and Diagnostics 190
- Lipoproteins and Cardiovascular Health 11
-
- Acute Myocardial Infarction Research 50
- Antiplatelet Therapy and Cardiovascular Diseases 30
- Atrial Fibrillation Management and Outcomes 14
- Co-authors
- Hans Erik Bøtker (95 shared papers)Lisette Okkels Jensen (112 shared papers)Steen Dalby Kristensen (75 shared papers)Henrik Toft Sørensen (66 shared papers)Jens Flensted Lassen (70 shared papers)Evald Høj Christiansen (88 shared papers)Leif Thuesen (54 shared papers)Per Thayssen (45 shared papers)
- Journals
- European Heart Journal (35 papers)Journal of the American College of Cardiology (33 papers)The American Journal of Cardiology (25 papers)EuroIntervention (22 papers)Catheterization and Cardiovascular Interventions (18 papers)
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Michael Mæng
343 papers receiving 14.4k citations
Michael Mæng's Hit Papers
Peers
Comparison fields: 5 of 128
- Cardiology and Cardiovascular Medicine 4.7k
- Surgery 8k
- Radiology, Nuclear Medicine and Imaging 1.5k
- Pathology and Forensic Medicine 529
- Internal Medicine 69
Countries citing papers authored by Michael Mæng
This map shows the geographic impact of Michael Mæng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mæng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mæng more than expected).
Fields of papers citing papers by Michael Mæng
This network shows the impact of papers produced by Michael Mæng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mæng. The network helps show where Michael Mæng may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Mæng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 367 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation Hit paper breakdown → | 2017 | 1041 |
| 2 | Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction Hit paper breakdown → | 2013 | 846 |
| 3 | Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI Hit paper breakdown → | 2017 | 752 |
| 4 | 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Hit paper breakdown → | 2022 | 627 |
| 5 | Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions Hit paper breakdown → | 2006 | 580 |
| 6 | Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial Hit paper breakdown → | 2016 | 572 |
| 7 | Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study Hit paper breakdown → | 2021 | 384 |
| 8 | ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting Hit paper breakdown → | 2015 | 354 |
| 9 | Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation Hit paper breakdown → | 2015 | 345 |
| 10 | 2014 | 292 | |
| 11 | Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial Hit paper breakdown → | 2019 | 269 |
| 12 | 2010 | 237 | |
| 13 | 2007 | 207 | |
| 14 | 2020 | 203 | |
| 15 | 2006 | 196 | |
| 16 | 1996 | 178 | |
| 17 | 2018 | 177 | |
| 18 | Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque Hit paper breakdown → | 2020 | 174 |
| 19 | 2010 | 169 | |
| 20 | 2013 | 168 |
About Michael Mæng
Michael Mæng is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 367 papers that have together received 15.1k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (190 papers), Acute Myocardial Infarction Research (50 papers), Cardiac Imaging and Diagnostics (43 papers), Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers), Atrial Fibrillation Management and Outcomes (14 papers), Cardiac Ischemia and Reperfusion (14 papers) and Lipoproteins and Cardiovascular Health (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (4.7k citations), Surgery (8k citations), Radiology, Nuclear Medicine and Imaging (1.5k citations), Pathology and Forensic Medicine (529 citations) and Internal Medicine (69 citations). Michael Mæng has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Hans Erik Bøtker, Lisette Okkels Jensen, Steen Dalby Kristensen, Henrik Toft Sørensen, Jens Flensted Lassen, Evald Høj Christiansen, Leif Thuesen, Per Thayssen, Anne Kaltoft and Kevin Kris Warnakula Olesen. Their work appears in journals such as European Heart Journal, Journal of the American College of Cardiology, The American Journal of Cardiology, EuroIntervention and Catheterization and Cardiovascular Interventions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.